Augusta Prosthetics & Orthotics, Inc.

Augusta Prosthetics & Orthotics, Inc., doing business as Augusta Prosthetics Inc., manufactures and delivers customized prosthetic and orthotic devices—including artificial limbs, molded sockets, electronic knees and hands, and advanced rehabilitation technologies—as a prime contractor exclusively to the Department of Veterans Affairs, competing on a full-and-open basis without set-aside designations.

Augusta Prosthetics is a small for-profit Subchapter S Corporation headquartered in Augusta, Georgia, registered as a federal contractor since February 2002. The company operates under primary NAICS 334511 (Surgical Appliance and Supplies Manufacturing) and PSC code 6520 (Medical and Surgical Instruments, Equipment, and Supplies). With 579 prime awards and no subcontract footprint, Augusta Prosthetics has maintained an exclusive relationship with a single customer: the Department of Veterans Affairs, Veterans Integrated Service Network 7 (VISN 7), which covers Georgia and surrounding states.

Customer concentration is near total. VISN 7 accounts for 547 awards (97% coverage) and $28.2 million of combined potential value across the portfolio. The Department of the Army Medical Command represents a secondary but minimal customer with three awards totaling $1 million; the broader Department of the Army holds thirteen additional awards. This single-customer dependence means Augusta Prosthetics' federal revenue derives almost entirely from VA prosthetic procurement.

Augusta Prosthetics places work under three primary vehicle structures anchoring its VA footprint. The VA Artificial Limb Manufacturing and Services 2016-2021 IDIQ generated 171 task orders with $3 million combined potential value, now expired. The incumbent position shifted to two active IDVs: an Indefinite Delivery Contract (36C24722D0025) valued at $107,068.50 (single-award, established March 1, 2022, with a completion date of May 31, 2022 in source but superseded by later awards) and a $1.5 million multiple-award Blanket Purchase Agreement (36C24722A0046) awarded June 1, 2022, expiring May 31, 2027. The BPA generated 86 task orders. Recent work under these vehicles includes transfemoral and transtibial limbs, molded sockets (AK and BK variants), electronic knee-shin systems, X-knee prosthetics, C-braces, electronic hands, and components such as replacement feet—ordered through individual purchase orders and BPA calls in the $10,000 to $73,000 range.

Activity has contracted materially. Awards peaked at 40 in 2023, fell to 27 in 2024, then to 23 in 2025, and have reached only 2 in 2026 year-to-date (snapshot taken July 15, 2026). Combined potential value across all 579 awards stands at $29.4 million, with $8.9 million obligated. Only one award reaches ultimate completion in the next twenty-four months, valued at $15,000, presenting minimal near-term recompete exposure—but the steep decline in annual award volume and the May 31, 2027 expiration of the $1.5 million BPA signals a likely transition or recompete event within eighteen months. The vendor holds no secondary or diversified federal customer base to offset VA concentration risk.

AOPI Orthotics and Prosthetics us committed to assisting each patient in maximizing their individual function and optimize their quality of life. Utilizing an onsite fabrication shop and laboratory, a professional staff provides competent, innovative and customized care, free of corporate rules and requirements while upholding fiscally responsible standards and providing quality and efficient care to each and every patient. AOPI promotes, participates and supports educational programs for patients, their families, healthcare professionals and the national orthotic and prosthetic community.